Skip to search.
 FTSE 100 Down 0.64%

Kite Pharma, Inc. (KITE)

-NasdaqGS
51.25 Up 3.46(7.24%) 31 May 21:00
|After Hours: : 51.25 0.00 (0.00%) 21:36
Prev Close:47.79
Open:48.11
Bid:48.50 x 100
Ask:51.50 x 200
1y Target Est:76.55
Beta:N/A
Next Earnings Date:28-Jul-16KITE Earnings announcement
Day's Range:48.06 - 51.52
52wk Range:38.41 - 89.84
Volume:888,520
Avg Vol (3m):914,244
Market Cap:2.52b
P/E (ttm):N/A
EPS (ttm):-2.89
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for KITE at this time.

Comparison

Symbol% ChgMkt Cap
KITEUp 7.24%2.52b
PFEUp 0.26%210.45b
CELGDown 0.86%81.74b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):120.38
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-5.56
Quarterly EPS Est (Jun-16) :-1.21
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Kite Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback